Quarterly Result30 May 2026, 08:51 pm
Samrat Pharmachem FY26: Revenue ₹28,972.12 Lakhs
AI Summary
Samrat Pharmachem Ltd. announced audited financial results for the quarter and year ended March 31, 2026. The Board of Directors approved the results at a meeting held on May 30, 2026. Revenue from operations for the year stood at ₹28,972.12 lakhs. The company's 34th AGM will be held on September 23, 2026.
Key Highlights
- Revenue from operations for FY26 is ₹28,972.12 lakhs.
- Net loss for FY26 is ₹331.20 lakhs.
- The 34th AGM is scheduled for September 23, 2026.
- Register of Members will be closed from September 17, 2026, to September 23, 2026.
Price Impact
More from SAMRATPH